Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells
Liyan Zhang, Nan Li, Ricardo Caicedo, Josef Neu, Liyan Zhang, Nan Li, Ricardo Caicedo, Josef Neu
Abstract
Certain probiotic bacteria show anti-inflammatory activity after being heat killed, whereas others do not, suggesting that the gastrointestinal environment may alter the activity of probiotic bacteria. Occasionally, probiotics are provided when a patient is also being treated with oral antibiotics; this may have an effect on the probiotic activity. We hypothesized that Lactobacillus rhamnosus GG (LGG) are capable of downregulating tumor necrosis factor-alpha (TNFalpha)-induced interleukin (IL)-8 production under all 3 of these conditions, and that LGG act through the nuclear factor kappaB (NFkappaB)/inhibitor of kappaB (IkappaB) pathway. Caco-2 cells were treated with live or heat-killed LGG in doses ranging from 10(4) to 10(10) cfu/L, in the presence or absence of antibiotics and TNFalpha in the media. TNFalpha-induced production of IL-8 by Caco-2 cells was modulated by LGG under all 3 conditions. However, higher doses of live LGG without TNFalpha in the presence or absence of antibiotics in vitro induced the production of IL-8 (P = 0.001). Heat-killed LGG also blunted the TNFalpha-induced IL-8 production (P < 0.01), but by itself did not increase IL-8 production at higher doses as markedly as live LGG (P < 0.05). LGG reduced the TNFalpha-induced NFkappaB translocation to the nucleus and lessened the decrease in IkappaB in the cytoplasm (P < 0.05). LGG reduced TNFalpha-induced IL-8 production by affecting the NFkappaB/IkappaB pathway in Caco-2 cells. High doses of live LGG markedly increased IL-8 production, but heat-killed LGG caused only a slight increase in IL-8. Thus, heat-killed LGG may effectively ameliorate inflammation with a lower potential than live LGG at high doses to cause inflammation.
Source: PubMed
다가오는 임상 시험
-
Wake Forest University Health Sciences아직 모집하지 않음
-
West China Second University Hospital아직 모집하지 않음잠 | 위 선암종 | 위식도 접합부 선암종 | 병리학적 반응
-
M.D. Anderson Cancer Center모병줄기세포 이식 | 젬시타빈 | 도세탁셀 | 카보플라틴 | 소아 재발 | 전향적 관찰 연구 | Melphalan | Refractory Germ미국
-
Washington University School of MedicineCompass Therapeutics아직 모집하지 않음
-
AstraZeneca아직 모집하지 않음제2형 당뇨병미국, 스페인, 덴마크, 헝가리, 중국, 대만, 남아프리카, 그리스, 아르헨티나, 일본, 대한민국, 터키 (Türkiye)
-
Arcus Biosciences, Inc.아직 모집하지 않음
-
West China Second University Hospital아직 모집하지 않음위 선암종 | 정신적 고통 | 위식도 접합부 선암종 | 병리학적 반응
-
West Virginia University아직 모집하지 않음
-
Arrowhead Pharmaceuticals아직 모집하지 않음
-
AstraZeneca아직 모집하지 않음제2형 당뇨병미국, 덴마크, 영국, 헝가리, 브라질, 베트남, 말레이시아, 대만, 중국, 독일, 그리스, 폴란드, 우크라이나, 체코, 일본, 푸에르토 리코, 아르헨티나, 대한민국
-
Boehringer Ingelheim아직 모집하지 않음비만 | 초과 중량미국, 호주, 영국, 캐나다, 중국, 뉴질랜드, 대한민국